Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions
- PMID: 35699243
- PMCID: PMC9350019
- DOI: 10.1111/jcpt.13709
Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions
Abstract
What is known and objective: The scope of clinical pharmacy services has changed during COVID-19 pandemic with the view to mitigating both exposure and spread of the virus. The performance of novel pandemic-driven services such as tele-pharmacy has remained unexplored, until now. The aim of this study is to investigate the perceptions of healthcare providers of the impact of tele-pharmacy services provided in critical care units during COVID-19.
Methods: A qualitative study of semi-structured interviews conducted with healthcare practitioners who worked in COVID-19 intensive care units and remotely interacted with clinical pharmacists at the Weill Cornell-affiliated Hamad Medical Corporation, Doha, Qatar. Random sampling technique was employed to recruit participants, with the resultant interview guide piloted before commencement of data collection process.
Results and discussion: From a total 129 and 200 physicians and nurses, respectively, 20 interviews were conducted with physicians (n = 15), and nurses (n = 5). From these interactions, a number of major themes emerged including: satisfactory understanding across clinical environment and personnel (physician and nurses) about remote clinical pharmacists' roles; additional robust feedback on the perception of the remote clinical pharmacy service; an understanding by 'frontline' health personnel on the discernible differences between remote and in-person coverage of clinical pharmacists; a reflection by both physicians and nurses on the novel challenges involved in the implementation of such pandemic-driven service; and solutions to overcome these challenges.
What is new and conclusion: In this novel qualitative study of pandemic-driven tele-pharmacy service, we found a positive perception amongst healthcare practitioners towards this service; with residual challenges that will need further evaluation by large sampled sized surveys or mixed methods research.
Keywords: COVID-19; clinical pharmacy; intensive care unit; qualitative; tele-pharmacy.
© 2022 The Authors. Journal of Clinical Pharmacy and Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
The study authors have no conflicts of interest to declare.
References
-
- World Health Organization . WHO coronavirus disease 2019 (COVID‐19) situation report‐52 [Internet]; 2021. Cited November 29, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Johns Hopkins Coronavirus Resource Center . COVID‐19 map – Johns Hopkins Coronavirus Resource Center [Internet]; 2021. Cited 5 April 2022. https://coronavirus.jhu.edu/map.html
-
- Whoint . Classification of omicron (B.1.1.529): SARS‐CoV‐2 variant of concern [Internet]; 2021. Cited 13 December 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....
-
- The Peninsula Qatar . HMC telemedicine service received 197,000 calls in 2020 [Internet]; 2021. Cited 2 September 2021. https://thepeninsulaqatar.com/article/26/01/2021/HMC-telemedicine-servic...
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
